News and Reports
Healthcare Finance: Trump's executive order on drugs seeks to end pharma 'pill penalty'
Merith Basey, executive director of Patients For Affordable Drugs, said the small molecule provision in the EO caves to pharmaceutical lobbyists’ demands. “Delaying Medicare negotiation for small-molecule drugs – the most commonly used medications – is a clear giveaway to Big Pharma,” Basey said. “It would hand drug companies four additional years to price-gouge patients, […]